Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-127544
Filing Date
2022-04-28
Accepted
2022-04-28 16:08:49
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d320937d10ka.htm   iXBRL 10-K/A 703983
2 EX-31.1 d320937dex311.htm EX-31.1 3625
3 EX-31.2 d320937dex312.htm EX-31.2 3656
  Complete submission text file 0001193125-22-127544.txt   998023

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wve-20211231.xsd EX-101.SCH 4650
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20211231_cal.xml EX-101.CAL 656
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20211231_def.xml EX-101.DEF 17843
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20211231_lab.xml EX-101.LAB 23449
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20211231_pre.xml EX-101.PRE 19426
10 EXTRACTED XBRL INSTANCE DOCUMENT d320937d10ka_htm.xml XML 6509
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37627 | Film No.: 22866569
SIC: 2834 Pharmaceutical Preparations